Prophylactic bilateral salpingo-oophorectomy - Revision history

Michael at 13:47, 17 June 2024

2024-06-17T13:47:05Z

← Older revision		Revision as of 13:47, 17 June 2024
Line 18:		Line 18:
	*[[Hereditary breast cancer]].		*[[Hereditary breast cancer]].
	*[[Sectioning and extensively examining of the fimbriated end]] (SEE-FIM).		*[[Sectioning and extensively examining of the fimbriated end]] (SEE-FIM).
			*[[Embedded in toto]].

	==References==		==References==

Michael at 13:46, 17 June 2024

2024-06-17T13:46:34Z

← Older revision		Revision as of 13:46, 17 June 2024
Line 5:		Line 5:

	==Grossing==		==Grossing==
	*Submit ovaries and tubes in total.<ref>{{cite journal \|authors=Fedda FA, Euscher ED, Ramalingam P, Malpica A \|title=Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature \|journal=Int J Gynecol Pathol \|volume=39 \|issue=4 \|pages=313–320 \|date=July 2020 \|pmid=31851061 \|doi=10.1097/PGP.0000000000000643 \|url=}}</ref><ref>{{cite journal \|authors=Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M \|title=Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls \|journal=Gynecol Oncol \|volume=127 \|issue=1 \|pages=88–93 \|date=October 2012 \|pmid=22710074 \|doi=10.1016/j.ygyno.2012.06.015 \|url=}}</ref>		*Submit ovaries and tubes [[submitted in total\|in total]].<ref>{{cite journal \|authors=Fedda FA, Euscher ED, Ramalingam P, Malpica A \|title=Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature \|journal=Int J Gynecol Pathol \|volume=39 \|issue=4 \|pages=313–320 \|date=July 2020 \|pmid=31851061 \|doi=10.1097/PGP.0000000000000643 \|url=}}</ref><ref>{{cite journal \|authors=Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M \|title=Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls \|journal=Gynecol Oncol \|volume=127 \|issue=1 \|pages=88–93 \|date=October 2012 \|pmid=22710074 \|doi=10.1016/j.ygyno.2012.06.015 \|url=}}</ref>

	==Sign out==		==Sign out==

Michael at 13:19, 17 June 2024

2024-06-17T13:19:42Z

← Older revision		Revision as of 13:19, 17 June 2024
Line 17:		Line 17:
	*[[Ovarian tumours]].		*[[Ovarian tumours]].
	*[[Hereditary breast cancer]].		*[[Hereditary breast cancer]].
			*[[Sectioning and extensively examining of the fimbriated end]] (SEE-FIM).

	==References==		==References==

Michael at 15:17, 9 June 2024

2024-06-09T15:17:23Z

← Older revision		Revision as of 15:17, 9 June 2024
Line 1:		Line 1:
	'''Prophylactic bilateral salpingo-oophorectomy''' are done to prevent the development of cancer - when there is a genetic predisposition.		'''Prophylactic bilateral salpingo-oophorectomy''' are done to prevent the development of cancer - when there is a genetic predisposition.

			==General==
			*The pathology yield in ''prophylactic bilateral salpingo-oophorectomies'' is significant but modest; in series of 26 prophylatic surgeries (BRCA1 22 individuals, BRCA2 4 individuals) there were 2 in situ carcinoma and 2 atypical proliferations.<ref name=pmid14668548>{{Cite journal \| last1 = Carcangiu \| first1 = ML. \| last2 = Radice \| first2 = P. \| last3 = Manoukian \| first3 = S. \| last4 = Spatti \| first4 = G. \| last5 = Gobbo \| first5 = M. \| last6 = Pensotti \| first6 = V. \| last7 = Crucianelli \| first7 = R. \| last8 = Pasini \| first8 = B. \| title = Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers. \| journal = Int J Gynecol Pathol \| volume = 23 \| issue = 1 \| pages = 35-40 \| month = Jan \| year = 2004 \| doi = 10.1097/01.pgp.0000101082.35393.84 \| PMID = 14668548 }}</ref> All of the pathology was in BRCA1 carriers.

	==Grossing==		==Grossing==

Michael: create

2024-05-21T16:09:25Z

create

← Older revision		Revision as of 16:09, 21 May 2024
Line 3:		Line 3:
	==Grossing==		==Grossing==
	*Submit ovaries and tubes in total.<ref>{{cite journal \|authors=Fedda FA, Euscher ED, Ramalingam P, Malpica A \|title=Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature \|journal=Int J Gynecol Pathol \|volume=39 \|issue=4 \|pages=313–320 \|date=July 2020 \|pmid=31851061 \|doi=10.1097/PGP.0000000000000643 \|url=}}</ref><ref>{{cite journal \|authors=Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M \|title=Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls \|journal=Gynecol Oncol \|volume=127 \|issue=1 \|pages=88–93 \|date=October 2012 \|pmid=22710074 \|doi=10.1016/j.ygyno.2012.06.015 \|url=}}</ref>		*Submit ovaries and tubes in total.<ref>{{cite journal \|authors=Fedda FA, Euscher ED, Ramalingam P, Malpica A \|title=Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature \|journal=Int J Gynecol Pathol \|volume=39 \|issue=4 \|pages=313–320 \|date=July 2020 \|pmid=31851061 \|doi=10.1097/PGP.0000000000000643 \|url=}}</ref><ref>{{cite journal \|authors=Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M \|title=Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls \|journal=Gynecol Oncol \|volume=127 \|issue=1 \|pages=88–93 \|date=October 2012 \|pmid=22710074 \|doi=10.1016/j.ygyno.2012.06.015 \|url=}}</ref>

			==Sign out==
			<pre>
			Fallopian Tubes and Ovaries, Bilateral Salpingo-Oophorectomy:
			- Benign ovaries and Fallopian tubes.
			- NEGATIVE for malignancy.
			</pre>

	==See also==		==See also==

Michael at 16:05, 21 May 2024

2024-05-21T16:05:51Z

← Older revision		Revision as of 16:05, 21 May 2024
Line 9:		Line 9:

	==References==		==References==
	{{~~Relist~~\|1}}		{{Reflist\|1}}

	[[Category:Gynecologic pathology]]		[[Category:Gynecologic pathology]]

Michael: create

2024-05-21T16:05:42Z

create

New page

'''Prophylactic bilateral salpingo-oophorectomy''' are done to prevent the development of cancer - when there is a genetic predisposition.

==Grossing==
*Submit ovaries and tubes in total.<ref>{{cite journal |authors=Fedda FA, Euscher ED, Ramalingam P, Malpica A |title=Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature |journal=Int J Gynecol Pathol |volume=39 |issue=4 |pages=313–320 |date=July 2020 |pmid=31851061 |doi=10.1097/PGP.0000000000000643 |url=}}</ref><ref>{{cite journal |authors=Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M |title=Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls |journal=Gynecol Oncol |volume=127 |issue=1 |pages=88–93 |date=October 2012 |pmid=22710074 |doi=10.1016/j.ygyno.2012.06.015 |url=}}</ref>

==See also==
*[[Ovarian tumours]].
*[[Hereditary breast cancer]].

==References==
{{Relist|1}}

[[Category:Gynecologic pathology]]